搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
6 天
Antibodies Could Soon Help Slow the Aging Process
The protective proteins in our bodies aren’t just great for fending off infection—they could also fight the effects of ...
2 天
on MSN
What to Know About Walking Pneumonia
Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can ...
Interesting Engineering on MSN
10 天
US scientists turn skin bacteria into topical vaccine, protect mice against tetanus
Stanford University scientists have now presented another unique method using a common skin bacterium, Staphylococcus ...
2 天
US FDA approves Novo Nordisk's bleeding disorder drug
The U.S. Food and Drug Administration has approved Novo Nordisk's drug for the prevention or reduction of bleeding episodes ...
News Medical
6 天
Enhancing therapeutic efficacy with antibody humanization
It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...
4 天
on MSN
Team offers an open solution to improving research reproducibility
Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in ...
Medscape
7 天
Monoclonal Antibodies in Rheumatoid Arthritis
There are currently four monoclonal antibodies available that are directed against TNF: infliximab, adalimumab, golimumab and certolizumab. All of these agents are efficacious in RA, with clinical ...
FierceBiotech
11 天
Harmless skin bacteria engineered to immunize mice against tetanus and diphtheria
It sounds a bit like something out of science fiction, but a topical vaccine that is rubbed on the skin is now closer to ...
BioSpace
7 天
Amyloid Hypothesis in Doubt as Newly Approved Drugs Hit Hurdles
Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈